EW · ISSUER CIK 1099800
Edwards Lifesciences Corp
Between Aug 1, 2026 and Oct 29, 2026, 5 Edwards Lifesciences Corp insiders reported $0.00 of open-market purchases and $3.5M of sales on SEC Form 4.
↗5 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 3 of 7 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$3.5MInsider selling
−$3.5MNet open-market
Oct 8, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 202617:24 | Oct 8, 2026 | EW | CVP, TAVR | S · Sell10b5-1 | $85.65 | −619 | 40,034 | -2% | −$53K | ||
| Oct 8, 202617:24 | Oct 8, 2026 | EW | CVP, TAVR | M · Exercise10b5-1 | $72.68 | +619 | 40,653 | +2% | $45K | ||
| Sep 14, 202618:04 | Sep 14, 2026from Sep 11, 2026 | EW | CVP, JAPAC | F · Tax | $85.29 | −923 | 19,371 | -5% | $79K | ||
| Sep 14, 202618:04 | Sep 13, 2026 | EW | SVP, Corporate Controller | F · Tax | $84.37 | −253 | 14,615 | -2% | $21K | ||
| Sep 11, 202619:15 | Sep 11, 2026 | EW | CVP, TMTT, Surgical & IHFM | F · Tax | $86.77 | −398 | 43,926 | -1% | $35K | ||
| Sep 11, 202619:15 | Sep 11, 2026 | EW | CVP, TAVR | S · Sell10b5-1 | $87.51 | −619 | 40,034 | -2% | −$54K | ||
| Sep 11, 202619:15 | Sep 11, 2026 | EW | CVP, TAVR | M · Exercise10b5-1 | $72.68 | +619 | 40,653 | +2% | $45K | ||
| Aug 31, 202617:47 | Aug 31, 2026 | EW | SVP, Corporate Controller | S · Sell | $91.06 | −544 | 14,868 | -4% | −$50K | ||
| Aug 28, 202616:32 | Aug 28, 2026 | EW | CVP, EMEACLA | S · Sell | $89.98 | −2,644 | 17,984 | -13% | −$238K | ||
| Aug 26, 202618:36 | Aug 26, 2026 | EW | CVP, TMTT, Surgical & IHFM | S · Sell | $91.02 | −31,800 | 44,324 | -42% | −$2.9M | ||
| Aug 26, 202618:36 | Aug 26, 2026 | EW | CVP, TMTT, Surgical & IHFM | M · Exercise | $72.68 | +31,800 | 76,124 | +72% | $2.3M | ||
| Aug 26, 202618:00 | Aug 26, 2026 | EW | CVP, JAPAC | S · Sell | $91.47 | −1,240 | 20,294 | -6% | −$113K | ||
| Aug 11, 202617:07 | Aug 11, 2026 | EW | CVP, TAVR | S · Sell10b5-1 | $92.03 | −619 | 40,034 | -2% | −$57K | ||
| Aug 11, 202617:07 | Aug 11, 2026 | EW | CVP, TAVR | M · Exercise10b5-1 | $72.68 | +619 | 40,653 | +2% | $45K |